Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Update

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 85,900 shares, a growth of 560.8% from the October 15th total of 13,000 shares. Based on an average trading volume of 266,400 shares, the days-to-cover ratio is presently 0.3 days.

Shionogi & Co., Ltd. Stock Down 1.2 %

Shares of OTCMKTS SGIOY traded down $0.08 during mid-day trading on Tuesday, reaching $6.85. The company had a trading volume of 274,993 shares, compared to its average volume of 147,612. Shionogi & Co., Ltd. has a twelve month low of $6.22 and a twelve month high of $9.11. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.37 and a current ratio of 5.86. The stock has a market capitalization of $12.19 billion, a PE ratio of 11.75, a price-to-earnings-growth ratio of 5.52 and a beta of 0.22. The stock’s 50 day moving average is $8.74 and its 200-day moving average is $10.04.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.